|
AADI
|
Aadi Biosciences, Inc.
|
US
|
NASDAQ
|
|
ACHL
|
Achilles Therapeutics plc
|
US
|
NASDAQ
|
|
ATNX
|
Athenex, Inc.
|
US
|
NASDAQ
|
|
BFRI
|
Biofrontera Inc.
|
US
|
NASDAQ
|
|
BNOX
|
Bionomics Limited
|
US
|
NASDAQ
|
|
BYSI
|
BeyondSpring, Inc.
|
US
|
NASDAQ
|
|
CLRB
|
Cellectar Biosciences, Inc.
|
US
|
NASDAQ
|
|
CNTX
|
Context Therapeutics Inc.
|
US
|
NASDAQ
|
|
CRDF
|
Cardiff Oncology, Inc.
|
US
|
NASDAQ
|
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
EFTR
|
eFFECTOR Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ERYP
|
Erytech Pharma S.A.
|
US
|
NASDAQ
|
|
HRTX
|
Heron Therapeutics, Inc.
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
MBRX
|
Moleculin Biotech, Inc.
|
US
|
NASDAQ
|
|
ORIC
|
Oric Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
PPBT
|
Purple Biotech Ltd.
|
US
|
NASDAQ
|
|
PYXS
|
Pyxis Oncology, Inc.
|
US
|
NASDAQ
|
|
RAIN
|
Rain Therapeutics Inc.
|
US
|
NASDAQ
|
|
SLS
|
SELLAS Life Sciences Group, Inc.
|
US
|
NASDAQ
|